Thyroid dysfunction in children with type 1 diabetes mellitus: prevalence, patterns and clinical associations
DOI:
https://doi.org/10.18203/2349-3291.ijcp20262422Keywords:
Autoimmune diseases, Glycated haemoglobin A, Hyperthyroidism, Hypothyroidism, Thyroiditis, AutoimmuneAbstract
Background: To determine the prevalence and pattern of thyroid dysfunction in children with Type 1 diabetes mellitus, identify associated risk factors that predispose diabetic children to develop thyroid abnormalities and evaluate the impact on glycemic control.
Methods: This prospective observational study included 50 children with Type 1 diabetes mellitus attending a tertiary care centre. Clinical characteristics, including age, gender, duration of diabetes, other autoimmune diseases, family history of autoimmunity, along with metabolic parameters like HbA1c and daily insulin requirement, were recorded. Thyroid status was categorised as euthyroid antibody negative, euthyroid antibody positive, subclinical hypothyroidism, overt hypothyroidism and hyperthyroidism. Associations between thyroid status and clinical variables, glycemic parameters were analysed.
Results: Thyroid dysfunction was present in 9 children (18%): subclinical hypothyroidism in 4 (8%), overt hypothyroidism in 4 (8%) and hyperthyroidism in 1 (2%). Among the remaining children, 28 (56%) were euthyroid with negative anti–thyroid peroxidase antibodies, while 13 (26%) were euthyroid with positive antibodies. Thyroid dysfunction was significantly associated with longer duration of diabetes and the coexistence of other autoimmune disorders. Daily insulin requirement differed significantly across thyroid subgroups, whereas glycated haemoglobin levels were comparable between T1DM children with and without thyroid dysfunction.
Conclusions: Thyroid dysfunction is common in children with Type 1 diabetes mellitus, affecting nearly one-fifth of patients, with subclinical hypothyroidism being a frequent abnormality. Longer duration and presence of other autoimmune diseases increase the risk of thyroid dysfunction. Periodic routine thyroid screening in children with Type 1 diabetes mellitus is essential for early detection and optimal metabolic management.
References
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Children and adolescents: Standards of care in diabetes. Diabetes Care. 2023;46(1):230–53.
Kordonouri O, Klinghammer A, Lang EB, Grüters-Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicentre survey. Diabetes Care. 2002;25(8):1346–50.
Mantovani RM, Mantovani LM, Dias VM. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus: prevalence and risk factors. J Pediatr Endocrinol Metab. 2007;20(6):669–75.
Menon PS, Vaidyanathan B, Kaur M. Autoimmune thyroid disease in Indian children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001;14(3):279–86.
Balsamo C, Zucchini S, Maltoni G, Rollo A, Martini AL, Mazzanti L, et al. Relationships between thyroid function and autoimmunity with metabolic derangement at the onset of type 1 diabetes: a cross-sectional and longitudinal study. J Endocrinol Invest. 2015;38(6):701–7.
Mohn A, Di Michele S, Di Luzio R, Tumini S, Chiarelli F. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus. Diabet Med. 2002;19(1):70–3.
Metwalley K, El-Saied AR. Thyroid abnormalities in Egyptian children and adolescents with type 1 diabetes mellitus: A single center study from Upper Egypt. Indian J Endocrinol Metab. 2014;18(5):637-41.
Narasimhegowda M, Rudrappa S, Gopal G. Thyroid function and thyroid autoimmunity in type 1 diabetes mellitus: impact on glycemic control. Int J Contemp Pediatr. 2023;10(9):1377–82.
Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013;6(1):14–7.
Hansen D, Bennedbaek F, Hansen LK, Hoier-Madsen M, Jacobsen BB, Hegedus L. Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur J Endocrinol. 1999;140(6):512–8.
Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens and their applicability in diagnosis and disease prediction. Endocr Rev. 2002;23(3):327–64.
Jonsdottir B, Larsson C, Carlsson A, Andersson C, Lernmark Å, Ivarsson SA, et al. Thyroid and islet autoantibodies predict autoimmune thyroid disease at type 1 diabetes diagnosis. J Clin Endocrinol Metab. 2017;102(4):1277-85.
Barker JM. Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations and screening. J Clin Endocrinol Metab. 2006;91(4):1210–7.
Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk. Diabetes. 2008;57(4):1084–92.
Mitrou P, Raptis SA, Dimitriadis G. Insulin action in hyperthyroidism: a focus on muscle and adipose tissue. Endocr Rev. 2010;31(5):663–79.
Shuhoub A, Aldrawani Z, Arab F. Assessment of Thyroid Function in Type 1 Diabetic Pediatric Patients And It’s Relation to Diabetes Severity. Zagazig Univ Med J. 2022;28(6):1340–5.
Fernández-Castañer M, Molina A, López-Jiménez L, Gómez JM, Soler J. Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity. Diabetes Care. 1999;22(3):377–81.
Fröhlich‐Reiterer E, Elbarbary NS, Simmons K, Carlson JA, Varney M, Concannon P, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2022;23(8):1451–67.
Downloads
Published
How to Cite
Issue
Section
